ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (year values) |
|||||||
2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 34.2% | 37.9% | 38.2% | 37.6% | ||
Changes by years, y/y, % | +4pp | +0pp | +5.7% |
ОЗОН Фармацевтика. EBITDA margin, %
ОЗОН Фармацевтика. EBITDA margin, changes, pp
ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 48.1% | 38.4% | 40.1% | 40.1% | 31.1% | 37.6% | |
Changes by years, y/y, % | +10pp | +10pp | -17pp | |||||
Changes by quarters, q/q, % | +18pp | -10pp | +2pp | 0pp | -9pp |